These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining. Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, Klein O, Vignaud JM. Am J Surg Pathol; 2008 Jul; 32(7):1051-9. PubMed ID: 18496143 [Abstract] [Full Text] [Related]
4. Renal cell carcinoma marker reliably discriminates central nervous system haemangioblastoma from brain metastases of renal cell carcinoma. Ingold B, Wild PJ, Nocito A, Amin MB, Storz M, Heppner FL, Moch H. Histopathology; 2008 May; 52(6):674-81. PubMed ID: 18393979 [Abstract] [Full Text] [Related]
5. Anti-alpha-inhibin: marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration. Fetsch PA, Powers CN, Zakowski MF, Abati A. Cancer; 1999 Jun 25; 87(3):168-72. PubMed ID: 10385449 [Abstract] [Full Text] [Related]
7. Expression of brachyury in hemangioblastoma: potential use in differential diagnosis. Barresi V, Vitarelli E, Branca G, Antonelli M, Giangaspero F, Barresi G. Am J Surg Pathol; 2012 Jul 25; 36(7):1052-7. PubMed ID: 22446946 [Abstract] [Full Text] [Related]
13. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases. Pan CC, Chen PC, Ho DM. Histopathology; 2004 Nov 25; 45(5):452-9. PubMed ID: 15500648 [Abstract] [Full Text] [Related]
16. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma. Browning L, Bailey D, Parker A. J Clin Pathol; 2008 Mar 25; 61(3):293-6. PubMed ID: 17660332 [Abstract] [Full Text] [Related]
17. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma. Khurana KK, Truong LD, Verani RR. Mod Pathol; 1998 Apr 25; 11(4):339-46. PubMed ID: 9578084 [Abstract] [Full Text] [Related]
18. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Cameron RI, Ashe P, O'Rourke DM, Foster H, McCluggage WG. Int J Gynecol Pathol; 2003 Jul 25; 22(3):272-6. PubMed ID: 12819395 [Abstract] [Full Text] [Related]